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Evidence suggesting a role for hydroxyl radical in puromycin
aminonucleoside-induced proteinuria. A single intravenous injection of
puromycin aminonucleoside (PAN) results in marked proteinuria and
glomerular morphological changes that are similar to minimal change
disease in humans. We examined the effect of hydroxyl radical scav-
engers and an iron chelator on PAN-induced proteinuria. PAN in a dose
of 5 mg/l00 g body wt significantly increased urinary protein by day 5
(saline: 15 2, N = 24: PAN: 63 17, N = 23, P C 0.001); the
proteinuria rapidly increased thereafter, reaching 216 34, N = 23 by
day 7. Concurrent administration of hydroxyl radical scavengers
dimethylthiourea, (DMTU 500 mg/kg followed by 125 mg/kg i.p. twice
a day) and sodium benzoate (BENZ, 150 mg/kg followed by 125 mg/kg
i.p. twice a day) starting the evening before PAN injection markedly
reduced proteinuria throughout the course of the study (urinary protein,
mg/24 hours on day 7, mean saM: PAN: 229 45, N 15; PAN +
DMTU: 30 5, N = 18; PAN + BENZ: 80 18, N = 16. Because of
the participation of iron in biological systems to generate hydroxyl
radical, we also examined the effect of deferoxamine (DFO, 30mg/day),
an iron chelator, on the PAN-induced proteinuria. Concurrent admin-
istration of DFO was also protective. In a second series of experiments,
DMTU and DFO (administered as described above and then for two
additional days after the PAN) provided marked protection even when
they were stopped prior to the onset of proteinuria. The protective
effects of two hydroxyl radical scavengers and iron chelator implicate
an important role for hydroxyl radical in PAN-induced nephrotic
syndrome.
A large body of in vitro, ex vivo and in vivo evidence support
the concept that reactive oxygen metabolites including free
radical species (such as superoxide and hydroxyl radical) and
other oxygen metabolites (for example, hydrogen peroxide and
hypochlorous acid) are important mediators of tissue injury
[1—4]. In particular, several recent studies indicate that reactive
oxygen metabolites may have an important role in the
pathophysiology of glomerular disease [1]. For example, reac-
tive oxygen metabolites have been shown to affect several
biological processes potentially important in glomerular dis-
ease, including prostaglandin synthesis [1, 5] and cyclic nude-
otide metabolism 16, 7]. Reactive oxygen metabolites can also
degrade glomerular basement membrane (in concert with metal-
loprotease) [8], and induce glomerular injury [9]. In addition, a
role for reactive oxygen metabolites has been recently demon-
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strated in several neutrophil-dependent glomerular diseases
[10—12].
A single intravenous injection of puromycin aminonucleoside
(PAN) results in marked proteinuria and glomerular morpho-
logical changes that are similar to minimal change disease in
humans [13]. Recently Diamond, Bonventre and Karnovsky
postulated that the glomerular injury associated with PAN was
mediated by oxygen free-radical generation since hypoxan-
thine, an intermediate metabolite of PAN, can serve as a
substrate for superoxide anion production via the xanthine
oxidase system [14]. They reported that allopurinol (an inhibitor
of xanthine oxidase) and superoxide dismutase were protective
in PAN-induced nephrotic syndrome, suggesting a role for
xanthine oxidase-generated superoxide anion in this model of
minimal change disease [14]. In biological systems, enhanced
generation of superoxide is accompanied by enhanced genera-
tion of other reactive oxygen metabolites. Thus phagocytic cells
[2—4], subcellular organdIes including mitochondria [15—17] and
microsomes [15] not only generate superoxide but also generate
hydrogen peroxide either by the direct divalent reduction of
oxygen or by the dismutation of superoxide. Similarly, the in-
teraction between xanthine and xanthine oxidase has been shown
to generate superoxide anion and hydrogen peroxide [4, 18].
Superoxide anion and hydrogen peroxide may interact (with
iron as catalyst) to generate the hydroxyl radical [4, 19, 20].
This reaction, commonly referred to as the Haber-Weiss reac-
tion may be summarized as follows:
02- + Fe3 — 02 + Fe2
Fe2 + H202 —* Fe3 + 01+ + OW
02- + H202->02+ 0H + OW
Several studies have, in fact, shown that enhanced generation
of hydrogen peroxide and superoxide anion is accompanied by
enhanced generation of hydroxyl radical (or a similar highly
oxidizing species) [4, 15, 17, 18]. Recent in vivo studies have
demonstrated the protective effect of hydroxyl radical scaven-
gers and/or iron chelators in several models of tissue injury
[21—24] characterized by increased vascular permeability [21—
24]. These studies from other tissues thus suggest that hydroxyl
radical may alter glomerular vascular permeability leading to
proteinuria, a major manifestation of glomerular disease. In-
deed the role of hydroxyl radical has recently been demon-
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strated in anti-GBM antibody disease, a neutrophil-dependent
model of glomerular disease [12]. The ability of freshly isolated
glomeruli [25] or cultured mesangial cells [26, 27] to generate
reactive oxygen metabolites in response to several stimuli,
suggests that reactive oxygen metabolites may also play a role
in glomerular diseases that lack infiltrating leukocytes. Indeed,
we have recently provided evidence suggesting a role for
hydroxyl radical in passive Heymann nephritis in rat [28], a
model that resembles membranous nephropathy in humans.
The protective effect of superoxide dismutase suggests an
important role for superoxide anion in PAN-induced proteinur-
ia. We postulated that enhanced generation of superoxide anion
would lead to enhanced generation of hydroxyl radical which
would play a role in the proteinuna in this model. Therefore, the
aim of the present study was to examine the effect of hydroxyl
radical scavengers and an iron chelator in PAN-induced pro-
teinuria, a model for minimal change disease in humans.
Methods
Experimental Design
Adult male Sprague-Dawley rats that weighed 200 to 250 g
and had free access to water and standard rat chow were used
in these experiments. The rats were housed in individual
metabolic cages at least two days prior to injection of either
saline or PAN. Nephrotic syndrome was induced by a single
dorsal vein injection of PAN in a dose of 5 mg/100 g body weight
[14]. Urine was collected daily, and urinary protein was mea-
sured by using the Bio-Rad protein assay as described by the
manufacturer (Bio-Rad Labs, Richmond, California, USA). On
day 7 after injection (day of injection = day 0), rats were
sacrificed, plasma was obtained from the measurement of BUN
and/or creatinine and kidneys were obtained for histology. Urea
nitrogen and creatinine were measured in plasma samples using
the Beckman BUN Analyzer 2 and the Beckman Creatinine
Analyzer (Beckman Instruments, Fullerton, California, USA).
Interventional therapy
The effect of several hydroxyl radical scavengers and an iron
chelator on PAN-induced proteinuria was examined. Dimeth-
ylthiourea (DMTU) was administered in a dose of 500 mg/kg
intraperitoneally (i.p.; 150 mg/mI) the evening prior to the PAN
injection, followed by 125 mg/kg i.p. twice a day [21, 28, 29].
PAN rats that did not receive any interventional agents were
injected with saline at the same time and in the same volume as
the DMTU rats. A second hydroxyl radical scavenger, sodium
benzoate, was similarly administered in a dose of 150 mg/kg i.p.
twice a day [23, 28, 29]. The iron chelator deferoxamine B
mesylate (DFO; Desferal, Ciba-Geigy Corp., Summit, New
Jersey, USA) was administered intravenously (i.v.) in a dose of
30 mg/rat the evening prior to the PAN injection. At the same
time, deferoxamine was administered via an osmotic pump
(type 2ML 2, ALZA Corp. Palo Alto, California, USA) that
was implanted subcutaneously. The drug was reconstituted in
water at a concentration of 250 mg/ml, and the pumps (with a 2
ml capacity) delivered approximately 30 mg deferoxamine per
rat per day at a continuous rate of 5 p1/hr. Previous studies have
shown that constant plasma levels of the drug are maintained
when the deferoxamine is administered by this route [301.
In the first series of experiments, the hydroxyl radical scav-
engers and the iron chelator were administered until sacrifice; in
a second series of experiments, the administration of the
interventional agents was stopped two days following the PAN
injection (before the onset of proteinuria) and the rats sacrificed
on day 7.
Kidney histology
Light microscopy studies on renal tissue were performed by
one of us (PDW). For light microscopy, a portion of renal
cortex was fixed in 10% formalin, dehydrated and embedded in
glycol methacrylate; 2 x sections were cut and stained with
hematoxylin and eosin and periodic acid-Schiff stains and
examined with a Nikon Labophot light microscope.
Effect of DMTU on inulin clearance and effective renal
plasma flow
Rats were given an evening injection of DMTU 500 mg/kg i.p.
(150 mg/mI) and a morning injection of 125 mg/kg i.p. Control
rats received saline injections in the same volume as the DMTU
rats. The rats were anesthetized with mactin (100 mg/kg),
placed on temperature-regulated table, and catheters were
placed in jugular vein (for infusion of inulin and para-aminohip-
purate (PAH), in carotid artery for monitoring systemic arterial
pressure and obtaining blood samples, and a tracheal cannula
inserted. The bladder was catheterized for urine collection.
Concomitant with the surgical preparation, a priming dose of
10% inulin and 1% PAH in 0.9% saline was administered in a
volume of 0.2 ml/100 g body weight, followed by a constant
infusion for the duration of the study of 5% inulin with 0.5%
PAH in 0.9% saline at a rate of 0.5 ml/lOOg/hr. After a 60 minute
equilibration period, urine was collected over two 30 minute
periods, and blood samples obtained for measurement of hema-
tocrit, whole kidney clearance rates of PAH (effective renal
plasma flow rate, ERPF) and inulin. The mean arterial pressure
and hematocrit were similar in the DMTU-treated and saline-
treated controls. Inulin concentrations in plasma and urine were
determined by the anthrone method [31] and PAH concentra-
tions were determined by the method of Waugh and Beall [32].
Results
The time course of proteinuria in rats injected with PAN in a
dose of 5 mg/100 g body wt is shown in Figure 1. The increased
urinary protein was first apparent on day 4 in some rats, but by
day 5 was significantly increased (saline: 15 2, N = 24; PAN:
63 17, N = 23; P < 0.001) in virtually all rats. The proteinuria
rapidly increased thereafter reaching 216 34, N = 23 by day
7. The kidney histology, performed on tissues obtained on day
7, was similar to that described in previous studies [13]. The
epithelial cells were enlarged and contained prominent cyto-
plasmic vacuoles and numerous eosinophilic granules ("protein
reabsorption droplets"). No endocapillary cell proliferation,
sclerosis, mesangial abnormalities or neutrophil infiltration was
apparent (Fig. 2).
We examined the effect of DMTU, a hydroxyl radical scav-
enger on PAN-induced proteinuria. Rats injected with DMTU
in addition to PAN had a marked reduction in proteinuria (Fig.
3) throughout the course of the study (P < 0.001 on day ?
compared to PAN group). We also examined the effect ol
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Fig. 1. Time course of proteinuria in puromycin aminonucleoside
(PAN)-induced nephrosis. The data shown are the mean SE, The rats
were housed in individual metabolic cages at least two days prior to
injection of either saline (—El--) or PAN (——). PAN was injected by a
single intravenous injection in a dose of 5 mg/lO0 g body weight. Urine
was collected daily, and urinary protein was measured by using the
Bio-Rad protein assay.
another hydroxyl radical scavenger, sodium benzoate. Sodium
benzoate (in doses similar to that used by others and in our
previous studies [23, 28, 291) also resulted in marked reduction
(P < 0.005 on day 7) in proteinuria (Fig. 3). Because of the
participation of iron in biological systems to generate hydroxyl
radical, we also examined the effect of deferoxamine on the
PAN-induced proteinuria. As shown in Figure 3, there was a
marked and a significant reduction in proteinuria (P <0.005 on
day 7).
We considered the possibility that the hydroxyl radical
scavengers and the iron chelator might affect glomerular func-
tion and that a marked reduction in glomerular filtration rate
may be responsible for the reduction in the proteinuria. How-
ever, the serum urea nitrogen and serum creatinine were not
significantly different between the various treatment groups
(Table 1).
Although the proteinuria after PAN injection does not occur
until four to six days later, studies by Hoyer et al have shown
that the kidney is programmed very early after the PAN
injection to develop proteinuria [33]. We, therefore examined
whether DMTU and DFO are protective if their administration
is stopped before the onset of proteinuria. In a second series of
experiments, DMTU and DFO were administered as described
above and then for two additional days after the PAN (instead
of throughout the course of the experiment). As shown in
Figure 4, both DMTU and deferoxamine provided marked
protection (P < 0.01) even when they were stopped prior to the
onset of proteinuria.
Because the kidney is programmed very early after PAN
injection to develop proteinuria, delivery of PAN to the kidney
during the initial period of injury may alter the subsequent
development of proteinuria. We therefore examined inulin
clearance and ERPF in DMTU-treated and saline-treated con-
trols. DMTU was injected in the same dose and volume as used
in the studies described above and inulin clearance and ERPF
Fig. 2. Sections of kidney from a rat seven days after injection of PAN.
The epithelial cells are enlarged and contain numerous eosinophilic
granules ("protein reabsorption droplets"). No endocapillary cell pro-
liferation, mesangial abnormalities, sclerosis or neutrophil infiltration is
present.
was measured at a time when the rats would have received
PAN, There were no differences in the inulin clearances
[DMTU: 0.98 0,05 (N = 3); control: 0.95 0.02 (N = 3)
mI/min/l00 g body wt] or ERPF [DMTU: 4.2 0.72 (N = 3);
control: 3.4 0.72 (N = 3) ml/min!lOO g body wt] between
DMTU-treated rats and saline-treated control rats,
Discussion
In the present study, administration of the hydroxyl radical
scavengers, DMTU and sodium benzoate, and an iron chelator
deferoxamine, (either throughout the course of the study or for
two days after PAN injection) markedly attenuated the PAN-
induced proteinuria in rats. Both DMTU, a potent hydroxyl
radical scavenger [211, and the iron chelator deferoxamine have
been extensively used in recent studies to delineate a potential
role for hydroxyl radical in several models of tissue injury [12,
21—24]. The ability of DMTU to scavenge hydroxyl radical has
been well established in in vitro studies [211. In addition,
DMTU has been shown to achieve concentrations sufficient to
scavenge hydroxyl radical in vivo (half-life of 34 hours in rats)
[121. DMTU has been successfully used to prevent the in-
creased vascular permeability in rat lungs after exposure to a
variety of injurious agents including: hyperoxia [12] thermal
trauma [231, or, in isolated rat lung preparations, enzymatically-
generated oxygen metabolites [34]. In addition, DMTU was
recently shown to prevent proteinuria in anti-GBM antibody
disease in rabbits 1101. These studies have been interpreted to
implicate hydroxyl radical in tissue injury. However, it should
be noted that a recent study by Wasil et al [35] indicates that
DMTU is also able to scavenge hypochlorous acid, the product
generated by the neutrophil myeloperoxidase-hydrogen perox-
ide and halide system. Thus in neutrophil-dependent injuries
the protective effects may be either due to the scavenging of
hydroxyl radical or by the scavenging of hypochiorous acid.
PAN-induced proteinuria is a neutrophil-independent injury; in
this setting it is thus likely that its protective effect is related to
its ability to scavenge hydroxyl radical. In addition, the protec-
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Fig. 3. The effect of hydroxyl radical scavengers and an iron chelator on PAN-induced proteinuria. Symbols are: () saline, N = 16; (LI) PAN,N = 15; () DMTU, N = 18; () benzoate, N = 16; (1J) DFO, N = 16. All groups received a single intravenous injection of PAN in a dose of
5 mgI 100 gm body weight except the saline group that received a single intravenous injection of saline. DMTU was administered in a dose of 500
mg/kg intraperitoneally the evening prior to the PAN injection followed by 125 mg/kg i.p. twice a day. Sodium benzoate administered in a dose
of 150 mg/kg i.p. twice a day. The iron chelator deferoxamine was administered intravenously in a dose of 30 mg/rat just prior to the PAN injection.
Deferoxamine was also administered via an osmotic pump that was implanted subcutaneously the previous evening. The drug was reconstituted
in water at a concentration of 250 mg/ml, and the pumps (with a 2 ml capacity) delivered approximately 30 mg deferoxamine per rat per day at
continuous rate of 5 gd/hr. The data shown are the mean sa. Asterisks denote P < 0.05 or a greater level of significance when compared to PAN
group, using an unpaired t-test.
N
Plasma urea nitrogen Plasma creatinine
mg/dl
Saline
PAN
PAN +
PAN +
PAN +
DMTU
benzoate
DFO
16
15
18
16
16
18
18
17
16
19
1
2
1
1
2
0.37 0.03
0.47 0.05
0.43 0.01
0.40 0.02
0.46 0.03
tive role of sodium benzoate and an iron chelator strongly
implicate the hydroxyl radical.
Iron chelators, including deferoxamine and 2,3,dihydroxy-
benzoic acid, have been shown to be protective in several in
vivo models of tissue injury [23, 24, 361 including anti-GBM
antibody disease in rabbits [101. Although the role of iron is not
completely understood, the protective effect of iron chelators
has been generally taken as evidence for the participation of
hydroxyl radical in tissue injury because iron is critical in the
generation of hydroxyl radical via the Haber-Weiss reaction.
Indeed, in in vitro studies, the ability of deferoxamine to block
the generation of hydroxyl radical has been well demonstrated
[37]. The requirement for iron could also be explained by a
reaction involving the formation of the perferryl ion [201. The
generation of the perferryl ion does not require hydrogen
peroxide but does require iron, NADPH-cytochrome P-450
reductase, NADPH, and oxygen. In our study, the effective-
ness of hydroxyl radical scavengers suggests that the role of
iron is related to its participation in the generation of hydroxyl
radical. Taken together, the protective effect of both the
hydroxyl radical scavengers and the iron chelators implicate a
role for hydroxyl radical in PAN-induced proteinuria.
Because the major source of hydroxyl radical in biological
Time, days
Fig. 4. The effect of DMTU (LI) and deferoxamine (-0—) on PAN-
induced proteinuria. Symbols are: (—El—), saline; (--) PAN. DMTU
and deferoxamine were administered as described in the Methods and
legend to Figure 3; the administration of these agents was stopped two
days after the PAN injection (prior to the onset of proteinuria).
systems is the interaction between superoxide and hydrogen
peroxide (in the presence of a trace metal such as iron) one
would anticipate that both superoxide dismutase and catalase
provide protection against PAN-induced proteinuria. Diamond
et al reported that superoxide dismutase provided protection
but catalase had no effect [14]. Protective effect of superoxide
dismutase and DMTU with a lack of protective effect of
catalase has been similarly reported for ischemic acute renal
failure [38]. While superoxide dismutase has been found to
localize in the kidney [391, because of its high molecular weight
(242,000) it is unlikely that catalase is able to scavenge intra-
cellularly generated hydrogen peroxide [40]. Thus, the lack of
protective effect of catalase does not exclude the role of
hydrogen peroxide either directly or as intermediate for the
IC0 .
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Table 1. Plasma urea nitrogen and creatinine in rats injected with
PAN and concurrently with hydroxyl radical scavengers or iron
chelator
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0
Plasma was obtained at the time of sacrifice (day 7) from same rats as
depicted in Figure 3. For experimental details see legend to Figure 3 and
Methods.
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generation of hydroxyl radical, Diamond et al also reported a
lack of protection by DMSO, a hydroxyl radical scavenger [141.
A similar lack of protective effect of DMSO has been found in
anti-GBM antibody disease. Thus Rehan et al found no reduc-
tion in proteinuria in rats injected with anti-GBM antibody and
concurrently receiving DMSO [11]. Boyce and Holdsworth
confirmed the lack of protective effect of DMSO in anti-GBM
antibody disease in rabbits but found marked protection with
DMTU and iron chelator, deferoxamine 1101. Thus the lack of
the protective effect of a particular oxygen radical scavenger
does not exclude the role of that radical in tissue injury. This
lack of protection may be related to the generation of toxic
methyl radicals or methylperoxy radicals by the interaction
between DMSO and hydroxyl radical [411.
The marked reduction in proteinuria by any agent may be
related to its ability to alter the metabolism and/or uptake or
binding of PAN [42] to the glomerular site of injury. DMTU in
doses similar to those used in our study has been previously
shown not to affect the renal blood flow [38]. Similarly we
observed no significant effect of DMTU on the inulin clearance
and on ERPF. In addition, the protective effect of two chemi-
cally dissimilar hydroxyl radical scavengers, DMTU and so-
dium benzoate, and of the iron chelator DFO, suggests this to
be an unlikely mechanism of the protective effect.
In summary, the protective effects of two hydroxyl radical
scavengers and an iron chelator implicate a role for hydroxyl
radical in the PAN-induced glomerular injury that results in
proteinuria.
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